An endocrine perspective on the role of steroid hormones in the antidepressant treatment efficacy of transcranial magnetic stimulation

Psychoneuroendocrinology

Volumn 35, Issue 1, 2010, Pages 171-178

  Schutter, Dennis J L G ^a   van Honk, Jack ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cortical excitability; Cortisol; Estradiol; Gamma amino butyric acid; Major depressive disorder; Steroid hormones; Testosterone; Transcranial magnetic stimulation; Treatment

Indexed keywords

CONTRACEPTIVE AGENT; ESTRADIOL; ETHINYLESTRADIOL; GLUCOCORTICOID ANTAGONIST; PLACEBO; PROGESTERONE; SERTRALINE; STEROID HORMONE; TESTOSTERONE;

BRAIN CORTEX; CLINICAL PROTOCOL; DRUG EFFICACY; DRUG POTENTIATION; EXCITABILITY; HUMAN; MAJOR DEPRESSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRANIAL MAGNETIC STIMULATION;

COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HORMONES; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; STEROIDS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 71849106905     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.04.009     Document Type: Review

References (65)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (2000), American Psychiatric Association, Washington, DC
2. Bajbouj M., Lisanby S.H., Lang U.E., Danker-Hopfe H., Heuser I., and Neu P. Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol. Psychiatry 59 (2006) 395-400
3. Baxter Jr. L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., and Selin C.E. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch. Gen. Psychiatry 46 (1989) 243-250
4. Belmaker R.H., and Agam G. Major depressive disorder. N. Engl. J. Med. 358 (2008) 55-68
5. Breedlove S.M. Sexually dimorphism in the vertebrate nervous system. J. Neurosci. 12 (1992) 4133-4142
6. Carroll B.J., and Rubin R.T. Mifepristone in psychotic depression?. Biol. Psychiatry 63 (2008) e1
7. Daskalakis Z.J., Fitzgerald P.B., and Christensen B.K. The role of cortical inhibition in the pathophysiology and treatment of schizophrenia. Brain Res. Rev. 56 (2007) 427-442
8. de Kloet E.R., Ratka A., Reul J.M., Sutanto W., and van Eekelen J.A. Corticosteroid receptor types in brain: regulation and putative function. Ann. N. Y. Acad. Sci. 512 (1987) 351-361
9. DeBattista C., Belanoff J., Glass S., Khan A., Horne R.L., Blasey C., Carpenter L.L., and Alva G. Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol. Psychiatry 60 (2006) 1343-1349
10. Dennis C.L., Ross L.E., and Herxheimer A. Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database Syst. Rev. 4 (2008) CD001690
11. Ebinger, M., Sievers, C., Ivan, D., Schneider, H.J., Stalla, G.K. Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression? J. Psychopharmacol., doi:10.1177/0269881108092337, in press.
12. Fitzgerald P.B., Brown T.L., Daskalakis Z.J., de Castella A., and Kulkarni J. A study of transcallosal inhibition in schizophrenia using transcranial magnetic stimulation. Schizophr. Res. 56 (2002) 199-209
13. Fitzgerald P.B., Benitez J., de Castella A., Daskalakis Z.J., Brown T.L., and Kulkarni J. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am. J. Psychiatry 163 (2006) 88-94
14. Frey B.N., Lord C., and Soares C.N. Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates. Menopause Int. 14 (2008) 123-128
15. Funk A.P., and George M.S. Prefrontal EEG asymmetry as a potential biomarker of antidepressant treatment response with transcranial magnetic stimulation (TMS): a case series. Clin. EEG Neurosci. 39 (2008) 125-130
16. Gallagher P., Malik N., Newham J., Young A.H., Ferrier I.N., and Mackin P. Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst. Rev. 23 (2008) CD005168
17. Gentile S. The role of estrogen therapy in postpartum psychiatric disorders: an update. CNS Spectr. 10 (2005) 944-952
18. George M.S., Wassermann E.M., Williams W.A., Callahan A., Ketter T.A., Basser P., Hallett M., and Post R.M. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 6 (1995) 1853-1856
19. Giordano R., Pellegrino M., Picu A., Bonelli L., Balbo M., Berardelli R., Lanfranco F., Ghigo E., and Arvat E. Neuroregulation of the hypothalamus-pituitary-adrenal (HPA) axis in humans: effects of GABA-, mineralocorticoid-, and GH-Secretagogue-receptor modulation. ScientificWorldJournal 17 (2006) 1-11
20. Hallett M. Transcranial magnetic stimulation: a primer. Neuron 55 (2007) 187-199
21. Hausmann M., Tegenthoff M., Sänger J., Janssen F., Güntürkün O., and Schwenkreis P. Transcallosal inhibition across the menstrual cycle: a TMS study. Clin. Neurophysiol. 117 (2006) 26-32
22. Hoflich G., Kaper S., Hufnagel A., Ruhrmann S., and Möller H.J. Application of transcranial magnetic stimulation in treatment of drug-resistant major depression: a report of two cases. Hum. Psychopharmacol. 8 (1993) 361-365
23. Holderbach R., Clark K., Moreau J.L., Bischofberger J., and Normann C. Enhanced long-term synaptic depression in an animal model of depression. Biol. Psychiatry 62 (2007) 92-100
24. Holsboer F. High-quality antidepressant discovery by understanding stress hormone physiology. Ann. N. Y. Acad. Sci. 1007 (2003) 394-404
25. Holsboer F. How can we realize the promise of personalized antidepressant medicines?. Nat. Neurosci. Rev. 9 (2008) 638-646
26. Huang C.C., Wei I.H., Chou Y.H., and Su T.P. Huang effect of age, gender, menopausal status, and ovarian hormonal level on rTMS in treatment-resistant depression. Psychoneuroendocrinology 33 (2008) 821-831
27. Hulshoff Pol H.E., Cohen-Kettenis P.T., van Haren N.E.M., Peper J.S., Brans R.B.G., Cahn W., Schnack H.G., Gooren L.J.G., and Kahn R.S. Changing your sex changes your brain: influences of testosterone and estrogen on adult human brain structure. Eur. J. Endocrinol. 155 (2006) s107-s114
28. Huttenlocher P.R., and de Courten C. The development of synapses in striate cortex of man. Hum. Neurobiol. 6 (1987) 1-9
29. Inghilleri M., Conte A., Currà A., Frasca V., Lorenzano C., and Berardelli A. Ovarian hormones and cortical excitability. An rTMS study in humans. Clin. Neurophysiol. 115 (2004) 1063-1068
30. Keck M.E., Engelmann M., Müller M.B., Henniger M.S., Hermann B., Rupprecht R., Neumann I.D., Toschi N., Landgraf R., and Post A. Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. J. Psychiatr. Res. 34 (2000) 265-276
31. Klein E., Kreinin I., Chistyakov A., Koren D., Mecz L., Marmur S., Ben-Shachar D., and Feinsod M. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch. Gen. Psychiatry 56 (1999) 315-320
32. Luine V.N., Grattan D.R., and Selmanoff M. Gonadal hormones alter hypothalami GABA and glutamate levels. Brain Res. 747 (1997) 165-168
33. Malenka R.C., and Nicoll R.A. Long-term potentiation: a decade of progress?. Science 285 (1999) 1870-1874
34. Markopoulou K., Papadopoulos A., Juruena M.F., Poon L., Pariante C.M., and Cleare A.J. The ratio of cortisol/DHEA in treatment resistant depression. Psychoneuroendocrinology 34 (2009) 19-26
35. Moncrieff J., Wessely S., and Hardy R. Active placebos versus antidepressants for depression. Cochrane Database Syst. Rev. 1 (2004) CD003012
36. Morsink L.F., Vogelzangs N., Nicklas B.J., Beekman A.T., Satterfield S., Rubin S.M., Yaffe K., Simonsick E., Newman A.B., Kritchevsky S.B., and Penninx B.W. Associations between sex steroid hormone levels and depressive symptoms in elderly men and women: results from the Health ABC study. Psychoneuroendocrinology 32 (2007) 874-883
37. Padberg F., di Michele F., Zwanzger P., Romeo E., Bernardi G., Schule C., Baghai T., Ella R., Pasini A., and Rupprecht R. Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. Neuropsychopharmacology 27 (2002) 874-878
38. Park S.K., Strouse D.A., and Selmanoff M. Prolactin- and testosterone-induced inhibition of LH secretion after orchidectomy: role of catecholaminergic neurones terminating in the diagonal band of Broca, medial preoptic nucleus and median eminence. J. Endocrinol. 148 (1996) 291-301
39. Pascual-Leone A., Valls-Solé J., Wassermann E.M., and Hallett M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 117 (1994) 847-858
40. Peper J.S., Brouwer R.M., Schnack H.G., van Baal G.C., van Leeuwen M., van den Berg S.M., Delemarre-van de Waal H.A., Janke A.L., Collins D.L., Evans A.C., Boomsma D.I., Kahn R.S., and Hulshoff Pol H.E. Cerebral white matter in early puberty is associated with luteinizing hormone concentrations. Psychoneuroendocrinology 33 (2008) 909-915
41. Post A., and Keck M.E. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms. J. Psychiatr. Res. 35 (2001) 193-215
42. Quartarone A., Siebner H.R., and Rothwell J.C. Task-specific hand dystonia: can too much plasticity be bad for you?. Trends Neurosci. 29 (2006) 192-199
43. Rizzo V., Siebner H.S., Morgante F., Mastroeni C., Girlanda P., and Quartarone A. Paired associative stimulation of left and right human motor cortex shapes interhemispheric motor inhibition based on a Hebbian mechanism. Cereb. Cortex 19 (2009) 907-915
44. Rupprecht R., and Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 22 (1999) 410-416
45. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28 (2003) 139-168
46. Sale M.V., Ridding M.C., and Nordstrom M.A. Cortisol inhibits neuroplasticity induction in human motor cortex. J. Neurosci. 28 (2008) 8285-8293
47. Sar M., and Stumpf W.E. Distribution of androgenic-concentrating neurons in rat brain. In: Stumpf W.E., and Grant L.D. (Eds). Anatomical Neuroendocrinology (1975), Karger, Basel 120-133
48. Schutter D.J.L.G., van Honk J., Koppeschaar H.P.C., and Kahn R.S. Cortisol and reduced interhemispheric coupling between the left prefrontal and the right parietal cortex. J. Neuropsychiatry Clin. Neurosci. 14 (2002) 89-90
49. Schutter D.J.L.G., Peper J.S., Koppeschaar H.P.C., Kahn R.S., and van Honk J. Administration of testosterone increases functional connectivity in a cortico-cortical depression circuit. J. Neuropsychiatry Clin. Neurosci. 17 (2005) 372-377
50. Schutter D.J.L.G., and van Honk J. A framework for targeting alternative brain regions with repetitive transcranial magnetic stimulation in the treatment of depression. J. Psychiatry Neurosci. 30 (2005) 91-97
51. Schutter, D.J.L.G., Laman, D.M., van Honk, J., Vergouwen, A.C., Koerselman, G.F. Partial clinical response to two-weeks of 2 Hz repetitive transcranial magnetic stimulation to the right parietal cortex in depression. Int. J. Neuropsychopharmacol., doi:10.1017/S1461145708009553, in press.
52. Schutter D.J.L.G. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol. Med. 39 (2009) 65-75
53. Sell S.L., Craft R.M., Seitz P.K., Stutz S.J., Cunningham K.A., and Thomas M.L. Estradiol-sertraline synergy in ovariectomized rats. Psychoneuroendocrinology 33 (2008) 1051-1060
54. Stefan K., Kunesch E., Cohen L.G., Benecke R., and Classen J. Induction of plasticity in the human motor cortex by paired associative stimulation. Brain 123 (2000) 572-584
55. Stumpf W.E., and Sar M. Anatomical distribution of corticosterone-concentrating neurons in rat brain. In: Stumpf W.E., and Grant L.D. (Eds). Anatomical Neuroendocrinology (1975), Karger, Basel 254-261
56. Tecchio F., Zappasodi F., Pasqualetti P., de Gennaro L., Pellicciari M.C., Ercolani M., Squitti R., and Rossini P.M. Age dependence of primary motor cortex plasticity induced by paired associative stimulation. Clin. Neurophysiol. 119 (2008) 675-682
57. Thickbroom G.W. Transcrcanial magnetic stimulation and synaptic plasticity: experimental framework and human models. Exp. Brain Res. 180 (2007) 583-593
58. Velísková J. Estrogens and epilepsy: why are we so excited?. Neuroscientist 13 (2007) 77-88
59. Wassermann E.M., Wedegaertner F.R., Ziemann U., George M.S., and Chen R. Crossed reduction of human motor cortex excitability by 1 Hz transcranial magnetic stimulation. Neurosci. Lett. 250 (1998) 141-144
60. Weltzien F.A., Pasqualini C., Sébert M.E., Vidal B., Le Belle N., Kah O., Vernier P., and Dufour S. Androgen-dependent stimulation of brain dopaminergic systems in the female European eel (Anguilla anguilla). Endocrinology 147 (2006) 2964-2973
61. Yen S.S., and Laughlin G.A. Aging and the adrenal cortex. Exp. Gerontol. 33 (1998) 897-910
62. Young E.A., Kornstein S.G., Harvey A.T., Wisniewski S.R., Barkin J., Fava M., Trivedi M.H., and Rush A.J. Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psychoneuroendocrinology 32 (2007) 843-853
63. Young E.A., Kornstein S.G., Marcus S.M., Harvey A.T., Warden D., Wisniewski S.R., Balasubramani G.K., Fava M., Trivedi M.H., and John Rush A. Sex differences in response to citalopram: a STAR*D report. J. Psychiatr. Res. 43 (2009) 503-511
64. Ziemann U. TMS and drugs. Clin. Neurophysiol. 115 (2004) 1717-1729
65. Zwanzger P., Baghai T.C., Padberg F., Ella R., Minov C., Mikhaiel P., Schüle C., Thoma H., and Rupprecht R. The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychoneuroendocrinology 28 (2003) 376-385